Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. (“Novavax” or ...

Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to ...

How bad is this news for Novavax? Let's find out. Image source: Getty Images.

In a new study examining people with opioid or alcohol use disorder, prescriptions for Ozempic, Wegovy, Mounjaro, and ...

In the latest market close, Novavax (NVAX) reached $10.35, with a +1.97% movement compared to the previous day. The stock ...

Novavax announced Wednesday that the Food and Drug Administration (FDA) has placed a clinical hold on its application for a ...

Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.

The FDA approved the company's COVID vaccine in October 2023. The stock has gained 111% in the year to date, while the S&P 500 SPX has gained 22%. This content was created by MarketWatch, which is ...

Novavax’s decision has left managers of the Biologics Manufacturing Centre, which was built with nearly $130-million in federal funds, working to drum up other business for the 55,000-square-foot ...

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer. Jessica is a writer on the Wellness team with a focus on health ...

More than three years later, that partner, Novavax Inc., won’t be making vaccines at the publicly owned plant in Montreal for the 2024-2025 season, which is part of the reason the federal ...